Clinical trial Recruiting at 1 site Interventional Ages 49 to 65

Effect of rTMS on pneumonia in stroke patients with swallowing difficulties

Official title: Post Stroke Dysphagia: Effect of Adding Brain Neuromodulation to Conventional Therapy on the Prevalence of Stroke Associated Pneumonia.

Run by Cairo University · NCT06123650 · Data updated 2026-11-12

This study tests if adding a special brain treatment to regular therapy can help stroke patients with swallowing problems avoid pneumonia.

More Pneumonia trials

Quick facts

Study typeInterventional
Ages49 Years to 65 Years
SexAll
Enrollment70 (estimated)
SponsorCairo University
Academic / other
Locations1 site (Giza, Giza Governorate)
StatusRecruiting
StartedMarch 22, 2025
Main results expectedDecember 28, 2025
Study endsJanuary 27, 2026
Registry record updatedOctober 3, 2025
Trial IDNCT06123650 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are acute ischemic stroke patients aged 49 to 65 with moderate to severe dysphagia.

Probably not a fit

Patients with a history of previous strokes, cognitive deficits, or existing lung diseases may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the impact of adding low-frequency repetitive transcranial magnetic stimulation (rTMS) to conventional physical therapy for patients suffering from dysphagia after an acute ischemic stroke. Seventy patients will be randomly assigned to either a control group receiving sham rTMS or a study group receiving actual rTMS alongside a designed rehabilitation program. The study aims to assess the prevalence of aspiration pneumonia in these patients, utilizing various assessments to confirm dysphagia and pneumonia risk. The intervention consists of 12 sessions over four weeks, focusing on improving swallowing coordination and reducing pneumonia risk.

Why it matters

Potential benefit: If successful, this approach could significantly reduce the incidence of aspiration pneumonia in stroke patients with dysphagia.

How similar studies have gone: While rTMS has shown promise in improving dysphagia, its specific effect on pneumonia prevalence in stroke patients is novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. All the patients were diagnosed of stroke oropharyngeal dysphagia by a neurologist. Sever to moderate dysphagia (GUSS 0-14).
2. Severity of stroke ranged from mild to moderate according to NIHSS score (NIHSS less than or equal 16).
3. Patients' age ranged from 49 to 65 years old.
4. Patients had the ability to understand and follow instructions.
5. Patients were able to sit in upright position.

Exclusion Criteria:

1. History of previous stroke.
2. History of any swallowing problem.
3. History of any head and neck surgery or tumor that causes swallowing dysfunction.
4. Any lung disease or pneumonia on admission.
5. Patients with cognitive deficits or disturbed conscious level.
6. Patients on mechanical ventilator.
7. Patients with sensory or global aphasia.

Where it's running

  • Faculty of Physical Therapy, Cairo University
    Giza, Giza Governorate, Egypt
    Recruiting

Study contacts

  • Principal investigator: Engy B. Moustafa, PhD — Faculty of Physical Therapy, Cairo University, Egypt
  • Study coordinator: Engy B. Moustafa, PhD
  • Email: engybm.saleh@cu.edu.eg
  • Phone: 00201099445112

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.